The NanoKTN Supports The Significant Investment Of Funds For Collaborative Research In Nanotechnology 06 Jan 09
The Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK’s primary knowledge-based networks for Micro and Nanotechnologies, has announced its support for one of the largest funding rounds that has been made available to the micro and nanotechnology sector.
Graham Thatcher
Diabetes Alert - One Person Diagnosed Every Three Minutes In The UK 02 Jan 09
One person is diagnosed with diabetes every three minutes* in the UK, according to new figures from Diabetes UK.
Fabienne Jacquet
Building a Rapport 24 Dec 08
This feature has been provided by Jonathan Hart-Smith, Managing Director of CK Clinical Limited.
The feature contains useful information for rapport buliding.
Jonathan Hart-Smith - CK Clinical Limited
24 Dec 08
This feature has been provided by Jonathan Hart-Smith,
Managing Director of CK Clinical Limited.
The feature contains useful information for Hiring Managers.
Jonathan Hart-Smith - CK Clinical Limited
18 Dec 08
According to Diabetes UK, over 2.5 Million people in the UK suffer from diabetes, with half a million of them being unaware they have it.
There are 2 forms of diabetes, and the causes of both types are different, but both result in too much glucose (sugar) in the blood.
Editor
More Help To Get Young People Talking 18 Dec 08
A £12 million action plan to improve services for children and young people with speech, language and communication needs was launched today by Health Secretary Alan Johnson and Children's Secretary Ed Balls.
Editor
16 Dec 08
Naseem Javed, widely recognized as global authority on global corporate nomenclature, image and cyber-branding, author of Naming for Power. Naseem is on global name identity projects and lecturing at various conferences on these ICANN issues.
Naseem Javed
BIOTECH SECTOR LEADERS PRESENT GOVERNMENT WITH BLUEPRINT FOR 'SEISMIC' INDUSTRY CHANGE15 Dec 08
- Dossier admits UK biotech at breaking point.
- Sector can still flourish – but needs major investment.
- Industry calls for new investment partnership with government.
- Creation of two new investment super funds critical to future success.
Ramsay Smith - Media House
Put People Power Into Action To Improve The NHS, Say Phil Hope And Ara Darzi 05 Dec 08
Patients are being urged to put people power into action from today by rating the service they receive in hospitals using a new tool on the NHS website.
Editor
Big Pharma squares up to changes03 Dec 08
Paul Hartigan reports from the Financial Times Pharmaceutical Conference: London December 2nd and 3rd 2008
Paul Hartigan
02 Dec 08
Awards for Innovation, Export Achievement and NHS Partnership held at ERBI's Winter Ball at The Imperial War Museum, Duxford on November 29th 2008.
Aviva Grisby - Holdsworth Associates
Graduates Lack Knowledge and Skills?28 Nov 08
‘More universities should provide courses that offer hands-on experience to better prepare their students.’ This is the response from the Head of Cranfield Health, Professor Joe Lunec, after a report claimed that those leaving universities lacked the required knowledge and skills to progress in the UK’s pharmaceutical industry.
Naomie Stanford-Jones
Still No Progress: Mixed Sex Wards And Racial Inequalities 28 Nov 08
According to recent information from MIND, the leading mental health charity, Patient research released today by the Healthcare Commission has revealed that a shocking 68% of mental health inpatients are still being housed on mixed sex wards, showing no improvement on last year's figures
Editor
The real reason why GPs are hard to reach...26 Nov 08
Our eMarketing team at PharmiWeb Solutions often works with pharma brand teams to find new ways to reach healthcare professionals with news of the latest product or initiative. And sometimes, it can be challenging, with all of the pressures and time constraints that the average primary care practice faces.
Editor
Re-emerging infectious diseases24 Nov 08
We are facing a world where microbes once again have the potential to cause untreatable diseases, due to the resistance to virtually all available drugs. WHO suggests that even if the pharmaceutical industry were to step up the efforts to develop new drugs immediately, some diseases might still not have any effective therapies within the next ten years.
Visiongain
Merck Serono invests €300 million in state of the art biotechnology center19 Nov 08
It takes courage to invest €300 million in a production site during a time of financial turmoilâ€,pointed out Karl-Ludwig Kley, Executive Board Chairman of the pharmaceutical company Merck Serono, this week.
Olwen Glynn Owen
The Global Pain Market, 2008-202317 Nov 08
The global pain market generated total sales of $34bn in 2007 – but what will the figures be in the next 5 and 10 years? This report tells you.
The pain market has marked strengths and advantages, but is also limited by problems and concerns.
Suvitha Damodaran - Visiongain - Ltd
Combating counterfeit drugs14 Nov 08
White paper from CERAM highlights novel techniques to expose fake medicines and unlicensed manufacturing processes
Mandy Rymill - CERAM
14 Nov 08
The UK’s success as a global centre of biomedical excellence is under threat in the long-term. A new report by the Association of the British Pharmaceutical Industry (ABPI) has highlighted serious concerns about the supply of skills that support the research and development of new medicines.
Editor
The Global Anti-Addiction Market, 2008-202314 Nov 08
The global addiction market is significantly undervalued. The world’s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents?
Suvitha Damodaran - Visiongain Ltd
World Gastrointestinal Disorders10 Nov 08
The gastrointestinal (GI) disorders market has been one of the largest and most profitable therapeutic areas in the world pharmaceutical industry. With a reported $49.9bn in revenues in 2007, the GI disorders market competes consistently with cardiovascular diseases and oncology for the top 3 therapeutic areas in terms of market value.
Suvitha Damodaran - Visiongain
04 Nov 08
There is great potential for the women’s reproductive disorders therapeutics market – can you maximise your company’s potential in this growing market?
Andres Arias - Visiongain
04 Nov 08
NHS Direct estimate that one in five UK women over forty years of age suffer from stress incontinence and, whilst it is often caused by childbirth or menopause, it can affect any women at any age.
Sian Rees
Dyselxia Awareness Week03 Nov 08
Recent reports state that between four and five percent of the population suffer from Dyslexia. It is estimated that there are about 375,000 pupils in the UK with dyslexia and a total of some two million people who are severely affected. Yet it still can be difficult for parents to find the right help for their children.
Editor
Key Mechanism Behind Cancer Spread Is Explained 31 Oct 08
Scientists have discovered the two key processes that allow cancer cells to change the way they move in order to spread through the body, reports leading scientific journal 'Cell'
Editor
Postmenopausal Osteoporotic Patients Granted Treatment Options by the National Institute for Health and Clinical Excellence (NICE) 31 Oct 08
Procter & Gamble Pharmaceuticals (P&GP) acknowledges the publication of the new Technology Appraisal Guidance (TAG 160, for the primary prevention, and 161 for the secondary prevention, of osteoporotic fragility fractures in post-menopausal women) issued by NICE.
Sebastian Stokes -Red Door Communications
Researchers Find New Chemical Key That Could Unlock Hundreds Of New Antibiotics 31 Oct 08
Chemistry researchers at The University of Warwick and the John Innes Centre, have found a novel signalling molecule that could be a key that will open up hundreds of new antibiotics unlocking them from the DNA of the Streptomyces family of bacteria.
Editor
Bayer optimistic about future business trend30 Oct 08
Following a strong performance in the third quarter, the Bayer Group confirms its targets for 2008. “Despite the difficult environment we expect in the fourth quarter, we are confirming our guidance for 2008 as a whole,â€
Editor
Credit crunch threatens new medicines30 Oct 08
The global financial crisis could seriously delay the discovery and production of many new life-saving medicines, warns a major international conference.
Editor
29 Oct 08
The following is taken from the ABPI's Press Release dated 29th October 2008
ABPI press office